The global vaccine manufacturing market is anticipated to generate revenues worth USD 100 billion by 2025. According to the WHO, the global vaccination rate is nearly 85%, demonstrating the high clinical demand for vaccines. In addition to meeting the growing demand for vaccines, the developers of these pharmacological interventions are also plagued by high costs of development and complex production protocols. It is worth highlighting that the contemporary contract services market for vaccine manufacturing is highly fragmented. Having said that, numerous stakeholders are actively striving to expand their respective service portfolios through substantial acquisition activity.
I have highlighted below some of the most interesting insights from our study. You can also access additional details here.
Over 70 companies based in different regions across the globe claim to provide contract development, fill / finish and regulatory services in addition to manufacturing various types of vaccine
The market landscape includes both established players and new entrants, operating at various scales and capable of vaccinemanufacturing based on a variety of expression systems.
In order acquire competencies across the value chain and cater to the evolving needs of clients / sponsors, CMOs have actively invested in expanding their existing infrastructure and capabilities
In fact, according to our proprietary competitiveness analysis, over time, several vaccine CMOs have acquired multidisciplinary expertise and capabilities to offer services across the supply chain.
The demand for contract manufacturing for vaccines is expected to increase in the coming years; we believe stakeholders may have to expand their respective capacities to ensure consistent supply.
With an annualized growth rate of nearly 10% of the vaccine contract manufacturing market, we expect the developers to continue to outsource their manufacturing operations with initiatives across developed and emerging regions.
In the long-term, the projected opportunity is anticipated to be well distributed across various types of expression systems used for vaccine production, types of services offered across the value chain and scale of operation
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.